EDOC:NSD-Global X Telemedicine & Digital Health ETF (USD)

ETF | Others |

Last Closing

USD 9.323

Change

0.00 (0.00)%

Market Cap

USD 0.04B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-1.77 (-2.97%)

USD 65.59B
QQQM Invesco NASDAQ 100 ETF

-1.66 (-0.76%)

USD 46.74B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.19 (-0.36%)

USD 25.59B
ACWI iShares MSCI ACWI ETF

-0.37 (-0.30%)

USD 21.43B
CGABL The Carlyle Group Inc. 4.625% ..

-0.01 (-0.06%)

USD 16.14B
TSLL Direxion Shares ETF Trust - Di..

-3.91 (-28.50%)

USD 6.20B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 5.83B
ETHA iShares Ethereum Trust ETF

-0.73 (-3.67%)

USD 3.58B
NVDL GraniteShares 1.5x Long NVDA D..

-1.57 (-2.73%)

USD 3.52B
MAGS Roundhill Magnificent Seven ET..

-1.39 (-2.63%)

USD 2.32B

ETFs Containing EDOC

HDOC:CA 98.44 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.16% 25% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.16% 24% F 49% F
Trailing 12 Months  
Capital Gain 2.56% 56% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.56% 43% F 54% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -13.37% 13% F 22% F
Dividend Return -13.37% 13% F 21% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 16.37% 36% F 81% B-
Risk Adjusted Return -81.65% 6% D- 7% C-
Market Capitalization 0.04B 51% F 25% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.